Product
Satoreotide
1 clinical trial
1 indication
Indication
Neuroendocrine TumorsClinical trial
An International, Multicenter, Open-label Study to Evaluate Safety, Tolerability, Biodistribution, Dosimetry and Preliminary Efficacy of 177Lu-OPS201 for the Therapy of Somatostatin Receptor-positive Neuroendocrine Tumors (NETs)Status: Terminated, Estimated PCD: 2022-02-22